Trevi Therapeutics, Inc. (TRVI) Depreciation USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Trevi Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from 2018 to 2023.
  • Trevi Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $11 K, a 15.4% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Depreciation for 2023 was $81 K, a 88.4% increase from 2022.
  • Trevi Therapeutics, Inc. annual Depreciation for 2022 was $43 K, a 14% decline from 2021.
  • Trevi Therapeutics, Inc. annual Depreciation for 2021 was $50 K, a 6.38% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $81 K +$38 K +88.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $43 K -$7 K -14% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $50 K +$3 K +6.38% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $47 K +$8 K +20.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $39 K +$16 K +69.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $23 K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.